What is Northland Capmk’s Forecast for Enovix Q1 Earnings?

Enovix Co. (NASDAQ:ENVX) – Research analysts at Northland Capmk issued their Q1 2026 earnings per share estimates for Enovix in a research note issued on Thursday, February 20th. Northland Capmk analyst G. Richard anticipates that the company will earn ($0.27) per share for the quarter. The consensus estimate for Enovix’s current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix’s Q2 2026 earnings at ($0.27) EPS, Q3 2026 earnings at ($0.27) EPS and Q4 2026 earnings at ($0.27) EPS.

ENVX has been the topic of several other reports. Benchmark restated a “buy” rating and issued a $25.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a research note on Thursday, February 20th. Craig Hallum decreased their target price on shares of Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Finally, Janney Montgomery Scott downgraded Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a research report on Thursday, October 31st. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $20.30.

Enovix Price Performance

Shares of Enovix stock opened at $9.44 on Monday. Enovix has a one year low of $5.70 and a one year high of $18.68. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77. The stock has a market cap of $1.68 billion, a P/E ratio of -6.51 and a beta of 1.87. The stock’s fifty day moving average is $11.19 and its 200 day moving average is $10.27.

Enovix (NASDAQ:ENVX) last released its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The firm had revenue of $9.72 million during the quarter, compared to analysts’ expectations of $8.77 million.

Institutional Investors Weigh In On Enovix

A number of institutional investors have recently modified their holdings of ENVX. Fifth Third Bancorp raised its holdings in Enovix by 66.7% in the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock worth $27,000 after purchasing an additional 1,000 shares during the period. Hodges Capital Management Inc. increased its position in shares of Enovix by 1.8% in the fourth quarter. Hodges Capital Management Inc. now owns 57,500 shares of the company’s stock valued at $625,000 after buying an additional 1,000 shares in the last quarter. Wealthcare Advisory Partners LLC raised its stake in shares of Enovix by 6.2% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 20,952 shares of the company’s stock worth $228,000 after buying an additional 1,214 shares during the period. Victory Capital Management Inc. lifted its position in shares of Enovix by 6.8% during the 4th quarter. Victory Capital Management Inc. now owns 19,695 shares of the company’s stock valued at $214,000 after buying an additional 1,257 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its stake in Enovix by 6.7% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 21,656 shares of the company’s stock valued at $202,000 after acquiring an additional 1,367 shares during the period. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total value of $729,750.00. Following the completion of the transaction, the director now owns 99,497 shares in the company, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 15.70% of the company’s stock.

Enovix Company Profile

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.